The authors also showed that cells overexpressing DLX3 in TDO demonstrate an increase in alkaline phosphatase activity, mineral deposition, and osteocalcin promoter activity, which is consistent with the increased bone density observed in TDO patients. This evidence concerns the gene DLX3 and tricho-dento-osseous syndrome.